biologics safety
Pathogen Safety Today 2013
August 30 by Pharmaceuticals & Biotechnology Editor
As pathogens continue to adapt and develop so must your strategy to prevent contamination. With both the financial cost and the damage to reputation so high is it critical to keep at the cutting edg...
Pathogen Safety Today
October 09 by Pharmaceuticals & Biotechnology Editor
As pathogens continue to adapt and develop so must your strategy to prevent contamination. With both the financial cost and the damage to reputation so high is it critical to keep at the cutting edg...
62.5% of Biologics Professionals Have Strategy in Place to Mitigate Risks of Contamination
September 06 by Pharma IQWithin the next five years, the global biologics market is set to exceed $239 billion (£145 billion) in value, according to recent research by Bharat Book. As innovation brings down production costs a...
The Biggest Threats to the Safety of Biologics
August 17 by Andrea CharlesDr. Barbara J. Potts, Senior Consultant, Potts and Nelson Consulting, joins Andrea Charles from Pharma, IQ to discuss the biggest threats to the safety of biologics and which contaminants pr...
Buyer Beware: Are You Reducing the Risk of Adventitious Agents in your Raw Materials?
April 19 by Barbara J. PottsDr. Barbara J. Potts, Senior Consultant, Potts and Nelson Consulting, joins Pharma IQ ahead of the Ensuring Adventitious Agent Safety in Biologics Conference, taking place 17 to 19 October in M...
